The Center for the Neurobiological Investigation of Drug Abuse (CNIDA) was established in 1991 by a grant from NIDA.
The Specific Aims of the Center are: to provide an environment to promote collaborative and multidisciplinary research into the neurobiological mechanisms of drug abuse among scientists at Wake Forest University School of Medicine; to provide a focus for the training of students and postdoctoral fellows in contemporary methods for investigation of the neurobiological basis of drug abuse; and to serve as an information source to both the lay and scientific community on issues related to the neurobiological aspects of drug abuse and to serve as the scientific reference for treatment and prevention programs in the community. The Center will accomplish these goals through the activities of four cores and seven projects over this next funding period. The cores (Administration, Animal, Chemistry and PET Imaging) will provide services to the projects whose expertise spans from molecular biology to non-human primate self-administration. The projects are diverse, but their research encompasses a general theme to examine the neuronal adaptations occurring in brain as a result of drug use, and which mediate the transition from drug use to drug addiction. These projects utilize several animal models and technologies uniquely developed by the Center investigators. A large number (23) of faculty and research associates will directly participate in Center research, from the Departments of Physiology-Pharmacology and Radiology at Wake Forest University School of Medicine, as well as the Department of Chemistry at SUNY-Buffalo. The Center will continue to provide research training for undergraduates, graduate students and postdoctoral fellows and serve as a resource on the neurobiology of drug abuse to the scientific and lay communities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA006634-17
Application #
7390850
Study Section
Special Emphasis Panel (ZDA1-RXL-E (20))
Program Officer
Volman, Susan
Project Start
1991-09-30
Project End
2009-09-29
Budget Start
2008-04-15
Budget End
2009-09-29
Support Year
17
Fiscal Year
2008
Total Cost
$1,649,996
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Physiology
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Raab-Graham, Kimberly F; Niere, Farr (2017) mTOR referees memory and disease through mRNA repression and competition. FEBS Lett 591:1540-1554
Howlett, Allyn C; Abood, Mary E (2017) CB1 and CB2 Receptor Pharmacology. Adv Pharmacol 80:169-206
Deadwyler, Sam A; Hampson, Robert E; Song, Dong et al. (2017) A cognitive prosthesis for memory facilitation by closed-loop functional ensemble stimulation of hippocampal neurons in primate brain. Exp Neurol 287:452-460
John, William S; Nader, Michael A (2017) Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement. Drug Alcohol Depend 170:112-119
Blume, Lawrence C; Patten, Theresa; Eldeeb, Khalil et al. (2017) Cannabinoid Receptor Interacting Protein 1a Competition with ?-Arrestin for CB1 Receptor Binding Sites. Mol Pharmacol 91:75-86

Showing the most recent 10 out of 310 publications